Janssen Propulsid concomitant use with Nizoral contraindicated due to association with arrhythmias.
JANSSEN PROPULSID CONCOMITANT USE WITH NIZORAL CONTRAINDICATED because of the potential for prolonged QT interval and rare association with ventricular arrhythmia and torsades de pointes, new warnings in Propulsid's labeling state. Janssen Pharmaceutica informed pharmacists and physicians of the new safety information about the nocturnal heartburn treatment in letters sent out in early February.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth